* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
FRA:Q8T'
s PEG Ratio Range Over the Past 10 Years
Min: 0.21 Med: 0.24 Max: 0.33
Current: 0.22
During the past 7 years, OrbusNeich Medical Group Holdings's highest PEG Ratio was 0.33. The lowest was 0.21. And the median was 0.24.
FRA:Q8T's PEG Ratio is ranked better than 98.09% of 209
companies
in the Medical Devices & Instruments industry
Industry Median: 1.93
vs FRA:Q8T: 0.22
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
OrbusNeich Medical Group Holdings (FRA:Q8T) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
OrbusNeich Medical Group Holdings PEG Ratio Related Terms
OrbusNeich Medical Group Holdings PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, OrbusNeich Medical Group Holdings's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OrbusNeich Medical Group Holdings PEG Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, OrbusNeich Medical Group Holdings's PEG Ratio distribution charts can be found below:
* The bar in red indicates where OrbusNeich Medical Group Holdings's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
OrbusNeich Medical Group Holdings (FRA:Q8T) has a PEG Ratio of 0.19 as of Jul. 12, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on OrbusNeich Medical Group Holdings and its competitors. This is 21% below median its historical median of 0.24. Over the past decade, OrbusNeich Medical Group Holdings' PEG Ratio has ranged from 0.21 to 0.33. According to the industry distribution chart, OrbusNeich Medical Group Holdings ranks #4 out of 209 companies in the Medical Devices & Instruments industry, placing it in the top 1.9%.
Is OrbusNeich Medical Group Holdings' PEG Ratio too high?
OrbusNeich Medical Group Holdings' current PEG Ratio of 0.19 is 21% below median its 10-year median of 0.24. Over the past 10 years, this metric has ranged from a low of 0.21 to a high of 0.33. The Medical Devices & Instruments industry median PEG Ratio is 1.93. OrbusNeich Medical Group Holdings' value of 0.19 is 90.2% below this industry median. Based on the distribution chart, OrbusNeich Medical Group Holdings ranks #4 out of 209 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, OrbusNeich Medical Group Holdings has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does OrbusNeich Medical Group Holdings' PEG Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, OrbusNeich Medical Group Holdings ranks #4 out of 209 companies for PEG Ratio. This places OrbusNeich Medical Group Holdings in the top 2% of its industry — outperforming the majority of peers. The industry median PEG Ratio is 1.93. OrbusNeich Medical Group Holdings' value of 0.19 is 90.2% below this benchmark. Historically, OrbusNeich Medical Group Holdings' own PEG Ratio has ranged from 0.21 to 0.33 over the past decade. While the company's 10-year median is 0.24 vs. the industry median of 1.93, OrbusNeich Medical Group Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Devices & Instruments company?
The median PEG Ratio among Medical Devices & Instruments companies is 1.93, based on 209 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. OrbusNeich Medical Group Holdings's current PEG Ratio of 0.19 is 90.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on OrbusNeich Medical Group Holdings and its competitors. For the Medical Devices & Instruments industry, the median PEG Ratio is 1.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OrbusNeich Medical Group Holdings's current PEG Ratio is 0.19, which is 21% below median its own 10-year median of 0.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OrbusNeich Medical Group Holdings stock overvalued right now?
OrbusNeich Medical Group Holdings (FRA:Q8T) has a current PEG Ratio of 0.19. The stock's GF Value™ is €0.49, compared to a current price of €0.36 — trading 26.9% below its estimated fair value. The current PEG Ratio is 0.19, which is 21% below median its 10-year median of 0.24 and 90.2% below the Medical Devices & Instruments industry median of 1.93. OrbusNeich Medical Group Holdings' overall GF Score™ is 96/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For OrbusNeich Medical Group Holdings (FRA:Q8T), the current PEG Ratio is 0.19 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is OrbusNeich Medical Group Holdings (FRA:Q8T) Overvalued in 2026?
Based on GuruFocus' analysis, OrbusNeich Medical Group Holdings stock appears to be undervalued.
The current stock price of €0.36 is trading 26.9% below its estimated GF Value™ of €0.49.
Key valuation signals for FRA:Q8T:
PEG Ratio: 0.19 (21% below median its 10-year median of 0.24)
GF Value™: €0.49 vs. price of €0.36 (26.9% below fair value)
Industry Position: 90.2% below the Medical Devices & Instruments median (#4 of 209)
No single metric tells the full story. See the FRA:Q8T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
OrbusNeich Medical Group Holdings Business Description
OrbusNeich Medical Group Holdings Ltd is an investment holding company. The Company principally engaged in the manufacturing, trading, sales and marketing of medical devices/instruments used for the treatment of coronary and peripheral vascular diseases. The group has only one operating segment. The company has presence in APAC, EMEA, Japan, United States, The PRC, and Others of which majority of revenue comes from APAC.
96GF Score
Get the complete analysis for FRA:Q8T
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:Q8T has been successfully added to your 
